Champions Oncology (CSBR) EBITDA Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -247.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 338.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -420.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -362.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -218.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -6,191.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 1,763.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -9.81 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -973,444.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1,763.00 |
| Apr 30, 2026 | 1,551.00 |
| Jan 31, 2026 | 1,758.00 |
| Oct 31, 2025 | 118.00 |
| Jul 31, 2025 | -170.00 |
| Apr 30, 2025 | -1,383.00 |
| Jan 31, 2025 | 2,011.00 |
| Oct 31, 2024 | 320.00 |
| Jul 31, 2024 | 1,101.00 |
| Apr 30, 2024 | 420.00 |
| Jan 31, 2024 | -3,052.00 |
| Oct 31, 2023 | -1,696.00 |
| Jul 31, 2023 | -2,057.00 |
| Apr 30, 2023 | 392.00 |
| Jan 31, 2023 | -2,405.00 |
| Oct 31, 2022 | -377.00 |
| Jul 31, 2022 | 705.00 |
| Apr 30, 2022 | -91.00 |
| Jan 31, 2022 | 1,205.00 |
| Oct 31, 2021 | -188.00 |